Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Guangzhou Wondfo Biotech C-A (300482 CH)
Watchlist
32
Analysis
Health Care
•
China
Guangzhou Wondfo Biotech Co.,Ltd. was founded in 1992. The company's line of business includes manufacturing of medical diagnostic tests. Guangzhou Wondfo Biotech serves customers around the world.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Guangzhou Wondfo Biotech C-A
•
31 May 2026 18:23
Quiddity CSI Medical Jun26 Results: 5/6 Correctly Predicted; US$134mn One-Way Flows
All of the confirmed changes except for one CSI Medical ADD Shanghai MicroPort EP MedTech (688351 CH) were in our final expected ADDs/DELs list....
Janaghan Jeyakumar, CFA
Follow
85 Views
Share
bearish
•
Guangzhou Wondfo Biotech C-A
•
07 May 2026 19:11
Quiddity Leaderboard CSI Medical Jun26: Final Expectations
We estimate the CSI Medical June 2026 index rebalance to trigger one-way flow of ~US$319mn. The results could be announced on 29th May 2026.
Janaghan Jeyakumar, CFA
Follow
205 Views
Share
bearish
•
Guangzhou Wondfo Biotech C-A
•
16 Apr 2026 20:20
Quiddity Leaderboard CSI Medical Jun26: 3 ADDs/DELs Expected For Now But It Could Become 4
One potential ADD and one potential DEL are still close to the border and those names could trigger an extra index change depending on relative...
Janaghan Jeyakumar, CFA
Follow
196 Views
Share
bearish
•
Guangzhou Wondfo Biotech C-A
•
22 Jan 2026 15:03
Quiddity Leaderboard CSI Medical Jun26: Four Changes Possible; US$262mn One-Way
We estimate the CSI Medical June 2026 index rebalance to trigger flows of ~US$262mn one-way. Some names have multiple days to trade.
Janaghan Jeyakumar, CFA
Follow
275 Views
Share
bullish
•
Zhende Medical Co Ltd
•
20 Mar 2026 18:54
Quiddity Leaderboard CSI Medical Jun26: Some Names Still Close to the Border
Our current estimate of impacts for the expected index changes range from 0.6x ADV to 3.5x ADV. Individual flow sizes range from US$11mn to US$85mn
Janaghan Jeyakumar, CFA
Follow
185 Views
Share
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.69.1
x